Guangdong Lifestrong Pharmacy Co., Ltd. (SHE:301111)
20.51
+0.03 (0.15%)
Feb 4, 2026, 3:14 PM CST
SHE:301111 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 141.59 | 159.1 | 131.11 | 179.21 | 485.35 | 108.13 |
Short-Term Investments | 125.68 | 128.25 | 141.14 | 190.97 | 20.42 | - |
Trading Asset Securities | 72.61 | 34.81 | 72.86 | 81.32 | 48.04 | 26.29 |
Cash & Short-Term Investments | 339.88 | 322.16 | 345.11 | 451.51 | 553.81 | 134.42 |
Cash Growth | 1.18% | -6.65% | -23.57% | -18.47% | 312.00% | 32.01% |
Accounts Receivable | 87.29 | 85.23 | 74 | 71.01 | 97.57 | 81.3 |
Other Receivables | 4.64 | 2.69 | 3.34 | 2.01 | 1.94 | 3.89 |
Receivables | 91.93 | 87.91 | 77.34 | 73.02 | 99.51 | 85.19 |
Inventory | 88.29 | 90.13 | 83.43 | 70.69 | 51.91 | 55.26 |
Prepaid Expenses | - | 0 | - | - | - | - |
Other Current Assets | 14.88 | 14.99 | 3.78 | 5.73 | 3.62 | 8.17 |
Total Current Assets | 534.99 | 515.2 | 509.66 | 600.95 | 708.84 | 283.04 |
Property, Plant & Equipment | 109.01 | 115.24 | 58.59 | 55.94 | 74.55 | 91.48 |
Long-Term Investments | 193.21 | 219.41 | 238.08 | 181.28 | 33.47 | - |
Goodwill | 9 | 7.32 | - | - | - | - |
Other Intangible Assets | 29.25 | 29.88 | 30.18 | 7.83 | 7.89 | 8.09 |
Long-Term Deferred Tax Assets | 21.43 | 13.91 | 8.51 | 8.52 | 1.22 | 1.16 |
Long-Term Deferred Charges | 27.31 | 28.71 | 0.4 | - | - | - |
Other Long-Term Assets | 1.21 | 3.49 | 10.13 | 2.56 | 0.23 | - |
Total Assets | 925.41 | 933.17 | 855.54 | 857.07 | 826.2 | 383.78 |
Accounts Payable | 60.56 | 56 | 34.87 | 29.04 | 37.59 | 26.2 |
Accrued Expenses | 6.11 | 12.71 | 11.4 | 17.25 | 9.38 | 9.82 |
Current Portion of Leases | 31.16 | 1.29 | 3.87 | 0.16 | 0.93 | - |
Current Income Taxes Payable | 6.77 | 1.29 | 0.2 | 9.85 | 5.09 | 0.3 |
Current Unearned Revenue | 11.53 | 12.44 | 5.39 | 26.88 | 5.66 | 4.81 |
Other Current Liabilities | 11.63 | 11.13 | 10.24 | 10.19 | 7.44 | 6.95 |
Total Current Liabilities | 127.76 | 94.85 | 65.97 | 93.36 | 66.08 | 48.08 |
Long-Term Leases | 44.98 | 70.86 | 10.09 | - | 0.16 | - |
Long-Term Unearned Revenue | 0.45 | 0.7 | 1.28 | 5.04 | 7.45 | 9.21 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 1.66 | 3.07 |
Total Liabilities | 173.2 | 166.42 | 77.33 | 98.39 | 75.34 | 60.37 |
Common Stock | 160 | 160 | 160 | 160 | 160 | 120 |
Additional Paid-In Capital | 406.94 | 406.94 | 406.94 | 406.94 | 406.94 | 76.67 |
Retained Earnings | 181.27 | 197.4 | 209.23 | 191.73 | 183.91 | 126.73 |
Total Common Equity | 748.21 | 764.34 | 776.17 | 758.67 | 750.85 | 323.41 |
Minority Interest | 4 | 2.41 | 2.03 | -0 | - | - |
Shareholders' Equity | 752.21 | 766.75 | 778.21 | 758.67 | 750.85 | 323.41 |
Total Liabilities & Equity | 925.41 | 933.17 | 855.54 | 857.07 | 826.2 | 383.78 |
Total Debt | 76.15 | 72.15 | 13.95 | 0.16 | 1.09 | - |
Net Cash (Debt) | 263.74 | 250.01 | 331.15 | 451.35 | 552.72 | 134.42 |
Net Cash Growth | -20.76% | -24.50% | -26.63% | -18.34% | 311.19% | 32.01% |
Net Cash Per Share | 1.90 | 1.80 | 2.08 | 2.84 | 4.64 | 1.12 |
Filing Date Shares Outstanding | 160 | 160 | 160 | 160 | 160 | 120 |
Total Common Shares Outstanding | 160 | 160 | 160 | 160 | 160 | 120 |
Working Capital | 407.23 | 420.34 | 443.69 | 507.59 | 642.77 | 234.96 |
Book Value Per Share | 4.68 | 4.78 | 4.85 | 4.74 | 4.69 | 2.70 |
Tangible Book Value | 709.95 | 727.13 | 745.99 | 750.85 | 742.96 | 315.31 |
Tangible Book Value Per Share | 4.44 | 4.54 | 4.66 | 4.69 | 4.64 | 2.63 |
Buildings | - | 76.38 | 68.76 | 74.73 | 79.72 | 80.77 |
Machinery | - | 86.7 | 78.07 | 78.59 | 93.14 | 99.72 |
Construction In Progress | - | - | 0.72 | 0.72 | - | - |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.